CDSCO panel rejects Optimus Pharma Phase III CT protocol of Tofacitinib Ointment for androgenic alopecia Dr. Divya Colin20 July 2022 6:00 PM ISTNew Delhi: Citing that there is no scientific rationality data and supportive published literature, the Subject Expert Committee (SEC) functional...
Sanofi gets CDSCO Panel okay to study Dupilumab Dr. Divya Colin19 July 2022 6:00 PM ISTNew Delhi: Directing to include all Serious Adverse Events (SAEs) and adverse events (AEs) of test drug in the informed consent document, the Subject...
Mylan Gets CDSCO Panel Nod To Study COPD drug Revefenacin inhalation solution Dr. Divya Colin18 July 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Mylan Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under Central Drug...
Cipla Gets CDSCO Panel Nod To Study Inhaled Itraconazole Dry Powder for inhalation Dr. Divya Colin16 July 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Cipla has got the go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Roche anti-cancer drug Atezolizumab gets CDSCO panel nod for Metastatic Triple Negative Breast Cancer Rahul Verma15 July 2022 4:53 PM ISTBased on the justification provided by the pharmaceutical giant Roche, the Subject Expert Committee (SEC) functional under Central Drug Standard...
CDSCO panel nod to Roche anti cancer drug Atezolizumab for metastatic triple negative breast cancer Dr. Divya Colin14 July 2022 6:00 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical giant Roche, the Subject Expert Committee (SEC) functional under Central Drug...
CDSCO flags 26 formulations as not of standard quality Rahul Verma14 July 2022 4:12 PM ISTIn the latest drug safety alert, the apex drug regulatory body, the Central Drug Standard Control Organisation (CDSCO) has flagged 26 medicine batches...
Drug Alert: CDSCO flags 26 formulations as not of standard quality Dr. Divya Colin13 July 2022 6:15 PM ISTNew Delhi: In the latest drug safety alert, the apex drug regulatory body, the Central Drug Standard Control Organisation (CDSCO) has flagged 26...
CDSCO Panel rejects Lupin FDC of Tranexamic Acid and Mefenamic Acid Dr. Divya Colin11 July 2022 6:00 PM ISTNew Delhi: Rejecting the proposal presented by pharmaceutical major Lupin, the Subject Expert Committee (SEC) functional under Central Drug Standard...
Drug-makers to add Hyponatraemia as adverse effect in package insert of Olanzapine: CDSCO Panel Susmita Roy5 July 2022 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Alkem Labs secures CDSCO panel nod to conduct BE study of anti epileptic drug Farhat Nasim1 July 2022 6:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) recommended for grant of permission...
Biocon engages law firm for governance review after CBI arrests Ruchika Sharma1 July 2022 2:30 PM ISTNew Delhi: Drugmaker Biocon Ltd. has engaged an external law firm to do a comprehensive review of its governance processes involving consultants and...
